BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2011404)

  • 1. Erythroid expression of the 'helix-loop-helix' gene, SCL.
    Green AR; Salvaris E; Begley CG
    Oncogene; 1991 Mar; 6(3):475-9. PubMed ID: 2011404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation.
    Murrell AM; Bockamp EO; Göttgens B; Chan YS; Cross MA; Heyworth CM; Green AR
    Oncogene; 1995 Jul; 11(1):131-9. PubMed ID: 7624120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system.
    Visvader J; Begley CG; Adams JM
    Oncogene; 1991 Feb; 6(2):187-94. PubMed ID: 2000219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
    Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
    Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.
    Murrell AM; Green AR
    Oncogene; 1995 Feb; 10(4):631-9. PubMed ID: 7862440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
    Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
    Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.
    Robb L; Rasko JE; Bath ML; Strasser A; Begley CG
    Oncogene; 1995 Jan; 10(1):205-9. PubMed ID: 7824274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SCL transcription factor and differential regulation of macrophage differentiation by LIF, OSM and IL-6.
    Begley CG
    Stem Cells; 1994; 12 Suppl 1():143-9; discussion 149-51. PubMed ID: 7696958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
    Robb L; Begley CG
    Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line.
    Elwood NJ; Cook WD; Metcalf D; Begley CG
    Oncogene; 1993 Nov; 8(11):3093-101. PubMed ID: 8414511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythroid Krüppel-like factor exhibits an early and sequentially localized pattern of expression during mammalian erythroid ontogeny.
    Southwood CM; Downs KM; Bieker JJ
    Dev Dyn; 1996 Jul; 206(3):248-59. PubMed ID: 8896981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
    Curtis DJ; Robb L; Strasser A; Begley CG
    Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
    Shivdasani RA; Mayer EL; Orkin SH
    Nature; 1995 Feb; 373(6513):432-4. PubMed ID: 7830794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
    Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
    Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression of the putative transcription factor SCL associated with proviral insertion in the myeloid leukemic cell line WEHI-3BD-.
    Tanigawa T; Robb L; Green AR; Begley CG
    Cell Growth Differ; 1994 Jun; 5(6):557-61. PubMed ID: 8086334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of msim, a murine homologue of the Drosophila sim transcription factor.
    Moffett P; Dayo M; Reece M; McCormick MK; Pelletier J
    Genomics; 1996 Jul; 35(1):144-55. PubMed ID: 8661115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SCL protein displays cell-specific heterogeneity in size.
    Elwood NJ; Green AR; Melder A; Begley CG; Nicola N
    Leukemia; 1994 Jan; 8(1):106-14. PubMed ID: 8289474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steel factor affects SCL expression during normal erythroid differentiation.
    Miller BA; Floros J; Cheung JY; Wojchowski DM; Bell L; Begley CG; Elwood NJ; Kreider J; Christian C
    Blood; 1994 Nov; 84(9):2971-6. PubMed ID: 7524762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The helix-loop-helix gene SCL: implicated in T-cell acute lymphoblastic leukaemia and in normal haematopoietic development.
    Robb L; Begley CG
    Int J Biochem Cell Biol; 1996 Jun; 28(6):609-18. PubMed ID: 8673726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.